Your search for esrd returned 2 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Traci Dantoni remove
MPR First Report remove

Your search for esrd returned 2 results

Sort Results:

Relevant Recent
ACR/ARHP Annual Meeting 2013

Twice-Daily Tofacitinib Shows Sustained Efficacy Over 5 Years in RA

Tofacitinib 5mg or 10mg twice daily showed a consistent safety profile and sustained efficacy over 5 years in long-term extension studies for patients with rheumatoid arthritis, as presented at the 2013 ACR/ARHP Annual Meeting.
ACR/ARHP Annual Meeting 2013

CZP + MTX Demonstrate Favorable Long-Term Efficacy in Active RA

At the 2013 ACR/ARHP Annual Meeting, study authors presented that patients with active rheumatoid arthritis (RA) despite methotrexate (MTX), certolizumab pegol (CZP) + MTX maintained reduction in signs and symptoms through 5 years.